Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-10

Clinical Trial Update: The Role of Gut Microbiota in Heart Failure and Pre-Heart Failure With Preserved Ejection Fraction

View source ↗

Summary

A clinical trial investigating the role of gut microbiota in heart failure and pre-heart failure with preserved ejection fraction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Heart Failure | Status: WITHDRAWN